retatrutide fat loss trial Side Effects: What Patients Should Know First Retatrutide phase 3 data,

doi: 10.1002/oby.24067 63 ArillottaDFlorestaGGuirguisACorkeryJMCatalaniVMartinottiGet al

J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis

It can take an additional 2 to 4 months post-FDA approval to get to commercial output

For example, the UK SmPCs for liraglutide (Saxenda) and semaglutide (Wegovy/Ozempic), available via the Electronic Medicines Compendium (eMC), advise awareness of heart rate increases during treatment and recommend that clinicians consider discontinuation if a clinically relevant sustained rise in resting heart rate is observed

Some pharmacies or online retailers may ship pens that are closer to expiration, which limits your buffer

Bodybuilding or cosmetic use is a separate concern